BioSpace News Archive

Seegene Inc. announced on November 10 that it has received an overall rating of ‘B+' in the 2023 ESG evaluation conducted by the Korea Institute of Corporate Governance and Sustainability.

Madrigal Pharmaceuticals, Inc. today announced that Carole Huntsman has been appointed Chief Commercial Officer.

FORE Biotherapeutics today announced an oral presentation highlighting updated Phase 1/2a clinical data for plixorafenib (FORE8394; PLX8394), the company’s novel, investigational, small-molecule, next-generation, orally available selective inhibitor of BRAF alterations, will be given at the Society for Neuro-Oncology (SNO) 2023 Annual Meeting, taking place November 15-19, 2023, in Vancouver, Canada.

Sandoz, the global leader in generic and biosimilar medicines, has opened two new European facilities, in line with its ongoing plans to strengthen sustainable development and supply of critical medicines in Europe and beyond.